2020 had a research & development by business enterprise, pharmaceutical industry in current ppp $ of 4,276.12 million in Belgium, but it has now decreased by 127.96 million (-2.9%).
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Belgium
No matching regions
Similar regions to Belgium
Business R&D pharmaceutical in current PPP $
More indicators for Belgium
Government R&D in security as % of government support
0.57%
+0.04%
(2021)
Higher-education-finacing R&D financed by general university in local currency
5,852.10M
+13.15M
(2021)
R&D financed by rest of the world in local currency
26,260.79M
+4,084.35M
(2021)
Government R&D financed by rest of the world in local currency
6,925.35M
+684.87M
(2021)
Business R&D financed by rest of the world in local currency
16,271.76M
+2,762.21M
(2021)
Non-profit R&D growth rate
-8.8%
+7%
(2022)
Belgium Business R&D pharmaceutical in current PPP $ between 1998 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 4,276.12M | -127.96M |
| 2020 | 4,404.08M | +480.84M |
| 2019 | 3,923.24M | +466.75M |
| 2018 | 3,456.48M | +585.22M |
| 2017 | 2,871.26M | +253.85M |
| 2016 | 2,617.41M | +628.11M |
| 2015 | 1,989.30M | +40.78M |
| 2014 | 1,948.53M | +19.14M |
| 2013 | 1,929.38M | +73.38M |
| 2012 | 1,856.00M | +139.57M |
| 2011 | 1,716.43M | +350.29M |
| 2010 | 1,366.14M | +18.77M |
| 2009 | 1,347.38M | +33.60M |
| 2008 | 1,313.77M | +60.94M |
| 2007 | 1,252.83M | +116.30M |
| 2006 | 1,136.54M | +322.00M |
| 2005 | 814.54M | -38.05M |
| 2004 | 852.59M | +85.03M |
| 2003 | 767.56M | +61.72M |
| 2002 | 705.85M | -6.19M |
| 2001 | 712.04M | +133.97M |
| 2000 | 578.07M | +5.55M |
| 1999 | 572.52M | +78.86M |
| 1998 | 493.66M |